Jw Asset Management, LLC Eagle Pharmaceuticals, Inc. Transaction History

Jw Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 09, 2019	SELL	$46.61 - $58.45 $19.8 Million - $24.9 Million	-425,755 Closed	0 $0
Q4 2018 Feb 08, 2019	SELL	$36.72 - $67.73 $1.84 Million - $3.39 Million	-50,000 Reduced 10.51%	425,755 $17.2 Million
Q4 2017 Feb 12, 2018	SELL	$49.6 - $60.87 $2.48 Million - $3.04 Million	-50,000 Reduced 9.51%	475,755 $25.4 Million
Q3 2017 Nov 13, 2017	BUY	$46.62 - $60.36 $24.5 Million - $31.7 Million	525,755	525,755 $31.4 Million

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Jw Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Jw Asset Management, LLC with notifications on news.